Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Virpax® Pharmaceuticals Receives FDA Response and Guidance on MMS019

Virpax Pharmaceuticals (VRPX) halted on LUDP

August 18, 2021 9:40 AM EDT

Virpax Pharmaceuticals (NASDAQ: VRPX) halted on LUDP

... More

Small-cap Virpax (VRPX) Up 100% Today to Push Weekly Gains to Over 500% After Receiving FDA Guidance on SARS and Flu Treatment

August 18, 2021 9:36 AM EDT

Shares of Virpax Pharmaceuticals (NASDAQ: VRPX) are trading higher after the company said it received a guided response from the US Food and Drug Administration (FDA) concerning its treatment that protects against SARS and flu.

The FDA response brings clarity about MMS019, a... More

Virpax Pharmaceuticals (VRPX) Extends Gain, Now Up 140%

August 18, 2021 7:27 AM EDT

Virpax Pharmaceuticals (NASDAQ: VRPX) Extends Gain, Now Up 140%

... More

Virpax Pharmaceuticals (VRPX) Extends Yesterday's Gain, Up Another 65%

August 18, 2021 6:07 AM EDT

Virpax Pharmaceuticals (NASDAQ: VRPX) Extends Yesterday's Gain, Up Another 65%

Shares were Up 265% Yesterday
... More